nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ABCB1—kidney cancer	0.183	1	CbGaD
Norethindrone—CYP3A7—Temsirolimus—kidney cancer	0.0593	0.0954	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0593	0.0954	CbGbCtD
Norethindrone—CYP3A5—Temsirolimus—kidney cancer	0.0445	0.0715	CbGbCtD
Norethindrone—ABCB1—Temsirolimus—kidney cancer	0.0289	0.0466	CbGbCtD
Norethindrone—CYP3A4—Everolimus—kidney cancer	0.0257	0.0413	CbGbCtD
Norethindrone—ALB—Erlotinib—kidney cancer	0.0207	0.0334	CbGbCtD
Norethindrone—CYP3A7—Paclitaxel—kidney cancer	0.0203	0.0327	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0203	0.0327	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0181	0.0291	CbGbCtD
Norethindrone—CYP3A7—Sorafenib—kidney cancer	0.0181	0.0291	CbGbCtD
Norethindrone—CYP3A7—Vincristine—kidney cancer	0.0175	0.0282	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0175	0.0282	CbGbCtD
Norethindrone—CYP3A4—Temsirolimus—kidney cancer	0.0173	0.0279	CbGbCtD
Norethindrone—CYP3A5—Erlotinib—kidney cancer	0.0167	0.0268	CbGbCtD
Norethindrone—CYP3A5—Paclitaxel—kidney cancer	0.0153	0.0245	CbGbCtD
Norethindrone—ABCB1—Pazopanib—kidney cancer	0.0152	0.0245	CbGbCtD
Norethindrone—CYP3A7—Sunitinib—kidney cancer	0.0146	0.0235	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0146	0.0235	CbGbCtD
Norethindrone—ABCB1—Dactinomycin—kidney cancer	0.0139	0.0224	CbGbCtD
Norethindrone—CYP3A5—Sorafenib—kidney cancer	0.0136	0.0218	CbGbCtD
Norethindrone—CYP3A5—Vincristine—kidney cancer	0.0132	0.0212	CbGbCtD
Norethindrone—ABCB1—Gemcitabine—kidney cancer	0.011	0.0177	CbGbCtD
Norethindrone—CYP3A5—Sunitinib—kidney cancer	0.011	0.0177	CbGbCtD
Norethindrone—CYP2C19—Sorafenib—kidney cancer	0.0109	0.0176	CbGbCtD
Norethindrone—ABCB1—Erlotinib—kidney cancer	0.0109	0.0174	CbGbCtD
Norethindrone—ABCB1—Paclitaxel—kidney cancer	0.00993	0.016	CbGbCtD
Norethindrone—CYP3A4—Pazopanib—kidney cancer	0.00911	0.0147	CbGbCtD
Norethindrone—ABCB1—Sorafenib—kidney cancer	0.00882	0.0142	CbGbCtD
Norethindrone—ABCB1—Vinblastine—kidney cancer	0.00871	0.014	CbGbCtD
Norethindrone—ABCB1—Vincristine—kidney cancer	0.00857	0.0138	CbGbCtD
Norethindrone—ABCB1—Sunitinib—kidney cancer	0.00715	0.0115	CbGbCtD
Norethindrone—CYP3A4—Erlotinib—kidney cancer	0.0065	0.0105	CbGbCtD
Norethindrone—CYP3A4—Paclitaxel—kidney cancer	0.00595	0.00957	CbGbCtD
Norethindrone—ABCB1—Doxorubicin—kidney cancer	0.00535	0.00861	CbGbCtD
Norethindrone—CYP3A4—Sorafenib—kidney cancer	0.00529	0.0085	CbGbCtD
Norethindrone—CYP3A4—Vinblastine—kidney cancer	0.00522	0.00839	CbGbCtD
Norethindrone—CYP3A4—Vincristine—kidney cancer	0.00513	0.00825	CbGbCtD
Norethindrone—CYP3A4—Sunitinib—kidney cancer	0.00428	0.00689	CbGbCtD
Norethindrone—CYP3A4—Doxorubicin—kidney cancer	0.00321	0.00516	CbGbCtD
Norethindrone—Hydrocortisone—ANXA1—kidney cancer	0.000633	0.37	CrCbGaD
Norethindrone—Drospirenone—BCHE—kidney cancer	0.00039	0.228	CrCbGaD
Norethindrone—Dyspepsia—Everolimus—kidney cancer	0.000209	0.00119	CcSEcCtD
Norethindrone—Alopecia—Vincristine—kidney cancer	0.000209	0.00119	CcSEcCtD
Norethindrone—Depression—Paclitaxel—kidney cancer	0.000209	0.00119	CcSEcCtD
Norethindrone—Insomnia—Erlotinib—kidney cancer	0.000207	0.00118	CcSEcCtD
Norethindrone—Mental disorder—Vincristine—kidney cancer	0.000207	0.00118	CcSEcCtD
Norethindrone—Anaphylactic shock—Sorafenib—kidney cancer	0.000206	0.00117	CcSEcCtD
Norethindrone—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000206	0.00117	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000206	0.00117	CcSEcCtD
Norethindrone—Renal failure—Paclitaxel—kidney cancer	0.000206	0.00117	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Everolimus—kidney cancer	0.000205	0.00117	CcSEcCtD
Norethindrone—Myocardial infarction—Paclitaxel—kidney cancer	0.000205	0.00117	CcSEcCtD
Norethindrone—Fatigue—Everolimus—kidney cancer	0.000205	0.00117	CcSEcCtD
Norethindrone—Vomiting—Temsirolimus—kidney cancer	0.000203	0.00116	CcSEcCtD
Norethindrone—Immune system disorder—Gemcitabine—kidney cancer	0.000203	0.00115	CcSEcCtD
Norethindrone—Dyspepsia—Erlotinib—kidney cancer	0.000202	0.00115	CcSEcCtD
Norethindrone—Rash—Temsirolimus—kidney cancer	0.000202	0.00115	CcSEcCtD
Norethindrone—Dermatitis—Temsirolimus—kidney cancer	0.000201	0.00115	CcSEcCtD
Norethindrone—Breast disorder—Capecitabine—kidney cancer	0.000201	0.00115	CcSEcCtD
Norethindrone—Skin disorder—Sorafenib—kidney cancer	0.0002	0.00114	CcSEcCtD
Norethindrone—Headache—Temsirolimus—kidney cancer	0.0002	0.00114	CcSEcCtD
Norethindrone—Dizziness—Pazopanib—kidney cancer	0.000199	0.00113	CcSEcCtD
Norethindrone—Oedema—Sunitinib—kidney cancer	0.000199	0.00113	CcSEcCtD
Norethindrone—Alopecia—Gemcitabine—kidney cancer	0.000198	0.00113	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000198	0.00113	CcSEcCtD
Norethindrone—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000198	0.00113	CcSEcCtD
Norethindrone—Pulmonary embolism—Doxorubicin—kidney cancer	0.000198	0.00113	CcSEcCtD
Norethindrone—Fatigue—Erlotinib—kidney cancer	0.000198	0.00113	CcSEcCtD
Norethindrone—Gastrointestinal pain—Vinblastine—kidney cancer	0.000195	0.00111	CcSEcCtD
Norethindrone—Gastrointestinal pain—Everolimus—kidney cancer	0.000194	0.00111	CcSEcCtD
Norethindrone—Abdominal distension—Capecitabine—kidney cancer	0.000194	0.0011	CcSEcCtD
Norethindrone—Skin disorder—Sunitinib—kidney cancer	0.000193	0.0011	CcSEcCtD
Norethindrone—Vomiting—Pazopanib—kidney cancer	0.000191	0.00109	CcSEcCtD
Norethindrone—Rash—Pazopanib—kidney cancer	0.00019	0.00108	CcSEcCtD
Norethindrone—Nausea—Temsirolimus—kidney cancer	0.00019	0.00108	CcSEcCtD
Norethindrone—Dermatitis—Pazopanib—kidney cancer	0.00019	0.00108	CcSEcCtD
Norethindrone—Haemoglobin—Paclitaxel—kidney cancer	0.000189	0.00107	CcSEcCtD
Norethindrone—Abdominal pain—Vinblastine—kidney cancer	0.000189	0.00107	CcSEcCtD
Norethindrone—Headache—Pazopanib—kidney cancer	0.000189	0.00107	CcSEcCtD
Norethindrone—Oedema—Dactinomycin—kidney cancer	0.000188	0.00107	CcSEcCtD
Norethindrone—Abdominal pain—Everolimus—kidney cancer	0.000188	0.00107	CcSEcCtD
Norethindrone—Haemorrhage—Paclitaxel—kidney cancer	0.000188	0.00107	CcSEcCtD
Norethindrone—Gastrointestinal pain—Erlotinib—kidney cancer	0.000188	0.00107	CcSEcCtD
Norethindrone—Connective tissue disorder—Paclitaxel—kidney cancer	0.000185	0.00105	CcSEcCtD
Norethindrone—Dyspepsia—Sorafenib—kidney cancer	0.000182	0.00103	CcSEcCtD
Norethindrone—Abdominal pain—Erlotinib—kidney cancer	0.000181	0.00103	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—kidney cancer	0.00018	0.105	CrCbGaD
Norethindrone—Insomnia—Sunitinib—kidney cancer	0.00018	0.00102	CcSEcCtD
Norethindrone—Nausea—Pazopanib—kidney cancer	0.000179	0.00102	CcSEcCtD
Norethindrone—Convulsion—Vincristine—kidney cancer	0.000178	0.00101	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000178	0.00101	CcSEcCtD
Norethindrone—Fatigue—Sorafenib—kidney cancer	0.000178	0.00101	CcSEcCtD
Norethindrone—Erythema multiforme—Paclitaxel—kidney cancer	0.000178	0.00101	CcSEcCtD
Norethindrone—Hypersensitivity—Vinblastine—kidney cancer	0.000176	0.001	CcSEcCtD
Norethindrone—Photosensitivity reaction—Capecitabine—kidney cancer	0.000176	0.001	CcSEcCtD
Norethindrone—Weight increased—Capecitabine—kidney cancer	0.000175	0.000997	CcSEcCtD
Norethindrone—Hypersensitivity—Everolimus—kidney cancer	0.000175	0.000997	CcSEcCtD
Norethindrone—Dyspepsia—Sunitinib—kidney cancer	0.000175	0.000995	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000171	0.000976	CcSEcCtD
Norethindrone—Asthenia—Vinblastine—kidney cancer	0.000171	0.000974	CcSEcCtD
Norethindrone—Fatigue—Sunitinib—kidney cancer	0.000171	0.000974	CcSEcCtD
Norethindrone—Depression—Capecitabine—kidney cancer	0.000171	0.000974	CcSEcCtD
Norethindrone—Asthenia—Everolimus—kidney cancer	0.000171	0.000971	CcSEcCtD
Norethindrone—Immune system disorder—Paclitaxel—kidney cancer	0.00017	0.000965	CcSEcCtD
Norethindrone—Acute coronary syndrome—Capecitabine—kidney cancer	0.000169	0.000963	CcSEcCtD
Norethindrone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000169	0.00096	CcSEcCtD
Norethindrone—Renal failure—Capecitabine—kidney cancer	0.000169	0.00096	CcSEcCtD
Norethindrone—Myocardial infarction—Capecitabine—kidney cancer	0.000168	0.000957	CcSEcCtD
Norethindrone—Pruritus—Everolimus—kidney cancer	0.000168	0.000957	CcSEcCtD
Norethindrone—Anaphylactic shock—Vincristine—kidney cancer	0.000168	0.000956	CcSEcCtD
Norethindrone—Oedema—Vincristine—kidney cancer	0.000168	0.000956	CcSEcCtD
Norethindrone—Alopecia—Paclitaxel—kidney cancer	0.000166	0.000944	CcSEcCtD
Norethindrone—Thrombophlebitis—Doxorubicin—kidney cancer	0.000166	0.000944	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000165	0.000939	CcSEcCtD
Norethindrone—Asthenia—Erlotinib—kidney cancer	0.000165	0.000937	CcSEcCtD
Norethindrone—Mental disorder—Paclitaxel—kidney cancer	0.000165	0.000936	CcSEcCtD
Norethindrone—Urticaria—Sorafenib—kidney cancer	0.000164	0.000933	CcSEcCtD
Norethindrone—Photosensitivity—Doxorubicin—kidney cancer	0.000164	0.00093	CcSEcCtD
Norethindrone—Abdominal pain—Sorafenib—kidney cancer	0.000163	0.000928	CcSEcCtD
Norethindrone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000162	0.000924	CcSEcCtD
Norethindrone—Hepatobiliary disease—Capecitabine—kidney cancer	0.000162	0.000924	CcSEcCtD
Norethindrone—Pruritus—Erlotinib—kidney cancer	0.000162	0.000924	CcSEcCtD
Norethindrone—Fatigue—Dactinomycin—kidney cancer	0.000162	0.000922	CcSEcCtD
Norethindrone—Flatulence—Paclitaxel—kidney cancer	0.000161	0.000917	CcSEcCtD
Norethindrone—Tension—Paclitaxel—kidney cancer	0.00016	0.000913	CcSEcCtD
Norethindrone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000159	0.000907	CcSEcCtD
Norethindrone—Oedema—Gemcitabine—kidney cancer	0.000159	0.000907	CcSEcCtD
Norethindrone—Nervousness—Paclitaxel—kidney cancer	0.000159	0.000903	CcSEcCtD
Norethindrone—Dizziness—Vinblastine—kidney cancer	0.000158	0.000898	CcSEcCtD
Norethindrone—Dizziness—Everolimus—kidney cancer	0.000157	0.000895	CcSEcCtD
Norethindrone—Abdominal pain—Sunitinib—kidney cancer	0.000157	0.000893	CcSEcCtD
Norethindrone—Haemoglobin—Capecitabine—kidney cancer	0.000155	0.000881	CcSEcCtD
Norethindrone—Skin disorder—Gemcitabine—kidney cancer	0.000155	0.000881	CcSEcCtD
Norethindrone—Haemorrhage—Capecitabine—kidney cancer	0.000154	0.000877	CcSEcCtD
Norethindrone—Hepatitis—Capecitabine—kidney cancer	0.000154	0.000877	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000154	0.000875	CcSEcCtD
Norethindrone—Hypersensitivity—Sorafenib—kidney cancer	0.000152	0.000865	CcSEcCtD
Norethindrone—Insomnia—Vincristine—kidney cancer	0.000152	0.000864	CcSEcCtD
Norethindrone—Vomiting—Vinblastine—kidney cancer	0.000152	0.000863	CcSEcCtD
Norethindrone—Dizziness—Erlotinib—kidney cancer	0.000152	0.000863	CcSEcCtD
Norethindrone—Connective tissue disorder—Capecitabine—kidney cancer	0.000151	0.000862	CcSEcCtD
Norethindrone—Vomiting—Everolimus—kidney cancer	0.000151	0.00086	CcSEcCtD
Norethindrone—Renal impairment—Doxorubicin—kidney cancer	0.000151	0.000858	CcSEcCtD
Norethindrone—Rash—Everolimus—kidney cancer	0.00015	0.000853	CcSEcCtD
Norethindrone—Dermatitis—Everolimus—kidney cancer	0.00015	0.000852	CcSEcCtD
Norethindrone—Headache—Vinblastine—kidney cancer	0.00015	0.000851	CcSEcCtD
Norethindrone—Purpura—Doxorubicin—kidney cancer	0.000149	0.000848	CcSEcCtD
Norethindrone—Headache—Everolimus—kidney cancer	0.000149	0.000848	CcSEcCtD
Norethindrone—Abdominal pain—Dactinomycin—kidney cancer	0.000149	0.000846	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000148	0.000844	CcSEcCtD
Norethindrone—Asthenia—Sorafenib—kidney cancer	0.000148	0.000843	CcSEcCtD
Norethindrone—Hypersensitivity—Sunitinib—kidney cancer	0.000146	0.000833	CcSEcCtD
Norethindrone—Pruritus—Sorafenib—kidney cancer	0.000146	0.000831	CcSEcCtD
Norethindrone—Vomiting—Erlotinib—kidney cancer	0.000146	0.00083	CcSEcCtD
Norethindrone—Erythema multiforme—Capecitabine—kidney cancer	0.000146	0.000829	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000145	0.000825	CcSEcCtD
Norethindrone—Fatigue—Vincristine—kidney cancer	0.000145	0.000824	CcSEcCtD
Norethindrone—Rash—Erlotinib—kidney cancer	0.000145	0.000823	CcSEcCtD
Norethindrone—Dermatitis—Erlotinib—kidney cancer	0.000145	0.000822	CcSEcCtD
Norethindrone—Insomnia—Gemcitabine—kidney cancer	0.000144	0.00082	CcSEcCtD
Norethindrone—Headache—Erlotinib—kidney cancer	0.000144	0.000818	CcSEcCtD
Norethindrone—Pain in extremity—Doxorubicin—kidney cancer	0.000144	0.000817	CcSEcCtD
Norethindrone—Asthenia—Sunitinib—kidney cancer	0.000142	0.000811	CcSEcCtD
Norethindrone—Nausea—Vinblastine—kidney cancer	0.000142	0.000807	CcSEcCtD
Norethindrone—Somnolence—Gemcitabine—kidney cancer	0.000142	0.000806	CcSEcCtD
Norethindrone—Convulsion—Paclitaxel—kidney cancer	0.000142	0.000806	CcSEcCtD
Norethindrone—Migraine—Doxorubicin—kidney cancer	0.000141	0.000804	CcSEcCtD
Norethindrone—Affect lability—Doxorubicin—kidney cancer	0.000141	0.000804	CcSEcCtD
Norethindrone—Nausea—Everolimus—kidney cancer	0.000141	0.000804	CcSEcCtD
Norethindrone—Pruritus—Sunitinib—kidney cancer	0.00014	0.000799	CcSEcCtD
Norethindrone—Immune system disorder—Capecitabine—kidney cancer	0.000139	0.000792	CcSEcCtD
Norethindrone—Hypersensitivity—Dactinomycin—kidney cancer	0.000139	0.000788	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000138	0.000786	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000138	0.000783	CcSEcCtD
Norethindrone—Fatigue—Gemcitabine—kidney cancer	0.000137	0.000782	CcSEcCtD
Norethindrone—Gastrointestinal pain—Vincristine—kidney cancer	0.000137	0.000782	CcSEcCtD
Norethindrone—Dizziness—Sorafenib—kidney cancer	0.000136	0.000777	CcSEcCtD
Norethindrone—Nausea—Erlotinib—kidney cancer	0.000136	0.000775	CcSEcCtD
Norethindrone—Alopecia—Capecitabine—kidney cancer	0.000136	0.000775	CcSEcCtD
Norethindrone—Mood swings—Doxorubicin—kidney cancer	0.000136	0.000774	CcSEcCtD
Norethindrone—Mental disorder—Capecitabine—kidney cancer	0.000135	0.000768	CcSEcCtD
Norethindrone—Asthenia—Dactinomycin—kidney cancer	0.000135	0.000768	CcSEcCtD
Norethindrone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000133	0.000759	CcSEcCtD
Norethindrone—Oedema—Paclitaxel—kidney cancer	0.000133	0.000759	CcSEcCtD
Norethindrone—Abdominal pain—Vincristine—kidney cancer	0.000133	0.000756	CcSEcCtD
Norethindrone—Flatulence—Capecitabine—kidney cancer	0.000132	0.000752	CcSEcCtD
Norethindrone—Dizziness—Sunitinib—kidney cancer	0.000131	0.000747	CcSEcCtD
Norethindrone—Vomiting—Sorafenib—kidney cancer	0.000131	0.000747	CcSEcCtD
Norethindrone—Rash—Sorafenib—kidney cancer	0.00013	0.00074	CcSEcCtD
Norethindrone—Dermatitis—Sorafenib—kidney cancer	0.00013	0.00074	CcSEcCtD
Norethindrone—Breast disorder—Doxorubicin—kidney cancer	0.00013	0.000738	CcSEcCtD
Norethindrone—Skin disorder—Paclitaxel—kidney cancer	0.00013	0.000737	CcSEcCtD
Norethindrone—Headache—Sorafenib—kidney cancer	0.000129	0.000736	CcSEcCtD
Norethindrone—Vomiting—Sunitinib—kidney cancer	0.000126	0.000718	CcSEcCtD
Norethindrone—Rash—Sunitinib—kidney cancer	0.000125	0.000712	CcSEcCtD
Norethindrone—Dermatitis—Sunitinib—kidney cancer	0.000125	0.000712	CcSEcCtD
Norethindrone—Abdominal distension—Doxorubicin—kidney cancer	0.000125	0.000711	CcSEcCtD
Norethindrone—Headache—Sunitinib—kidney cancer	0.000124	0.000708	CcSEcCtD
Norethindrone—Hypersensitivity—Vincristine—kidney cancer	0.000124	0.000704	CcSEcCtD
Norethindrone—Nausea—Sorafenib—kidney cancer	0.000123	0.000698	CcSEcCtD
Norethindrone—Insomnia—Paclitaxel—kidney cancer	0.000121	0.000687	CcSEcCtD
Norethindrone—Asthenia—Vincristine—kidney cancer	0.000121	0.000686	CcSEcCtD
Norethindrone—Vomiting—Dactinomycin—kidney cancer	0.00012	0.00068	CcSEcCtD
Norethindrone—Somnolence—Paclitaxel—kidney cancer	0.000119	0.000675	CcSEcCtD
Norethindrone—Rash—Dactinomycin—kidney cancer	0.000119	0.000674	CcSEcCtD
Norethindrone—Nausea—Sunitinib—kidney cancer	0.000118	0.000671	CcSEcCtD
Norethindrone—Dyspepsia—Paclitaxel—kidney cancer	0.000117	0.000668	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000115	0.000655	CcSEcCtD
Norethindrone—Fatigue—Paclitaxel—kidney cancer	0.000115	0.000654	CcSEcCtD
Norethindrone—Asthenia—Gemcitabine—kidney cancer	0.000114	0.000651	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000113	0.000645	CcSEcCtD
Norethindrone—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000113	0.000645	CcSEcCtD
Norethindrone—Weight increased—Doxorubicin—kidney cancer	0.000113	0.000643	CcSEcCtD
Norethindrone—Pruritus—Gemcitabine—kidney cancer	0.000113	0.000641	CcSEcCtD
Norethindrone—Nausea—Dactinomycin—kidney cancer	0.000112	0.000635	CcSEcCtD
Norethindrone—Dizziness—Vincristine—kidney cancer	0.000111	0.000632	CcSEcCtD
Norethindrone—Progesterone—CYP1A1—kidney cancer	0.000111	0.0648	CrCbGaD
Norethindrone—Drowsiness—Doxorubicin—kidney cancer	0.000111	0.00063	CcSEcCtD
Norethindrone—Oedema—Capecitabine—kidney cancer	0.000109	0.000623	CcSEcCtD
Norethindrone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000109	0.000621	CcSEcCtD
Norethindrone—Renal failure—Doxorubicin—kidney cancer	0.000109	0.000619	CcSEcCtD
Norethindrone—Vomiting—Vincristine—kidney cancer	0.000107	0.000608	CcSEcCtD
Norethindrone—Skin disorder—Capecitabine—kidney cancer	0.000106	0.000605	CcSEcCtD
Norethindrone—Urticaria—Paclitaxel—kidney cancer	0.000106	0.000603	CcSEcCtD
Norethindrone—Rash—Vincristine—kidney cancer	0.000106	0.000603	CcSEcCtD
Norethindrone—Dermatitis—Vincristine—kidney cancer	0.000106	0.000602	CcSEcCtD
Norethindrone—Abdominal pain—Paclitaxel—kidney cancer	0.000105	0.0006	CcSEcCtD
Norethindrone—Headache—Vincristine—kidney cancer	0.000105	0.000599	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ABCB1—kidney cancer	0.000105	0.0615	CrCbGaD
Norethindrone—Testosterone—CYP1A1—kidney cancer	0.000105	0.0613	CrCbGaD
Norethindrone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000105	0.000595	CcSEcCtD
Norethindrone—Vomiting—Gemcitabine—kidney cancer	0.000101	0.000576	CcSEcCtD
Norethindrone—Rash—Gemcitabine—kidney cancer	0.0001	0.000572	CcSEcCtD
Norethindrone—Dermatitis—Gemcitabine—kidney cancer	0.0001	0.000571	CcSEcCtD
Norethindrone—Haemoglobin—Doxorubicin—kidney cancer	9.98e-05	0.000568	CcSEcCtD
Norethindrone—Headache—Gemcitabine—kidney cancer	9.98e-05	0.000568	CcSEcCtD
Norethindrone—Nausea—Vincristine—kidney cancer	9.98e-05	0.000568	CcSEcCtD
Norethindrone—Haemorrhage—Doxorubicin—kidney cancer	9.93e-05	0.000565	CcSEcCtD
Norethindrone—Hepatitis—Doxorubicin—kidney cancer	9.93e-05	0.000565	CcSEcCtD
Norethindrone—Insomnia—Capecitabine—kidney cancer	9.9e-05	0.000563	CcSEcCtD
Norethindrone—Hypersensitivity—Paclitaxel—kidney cancer	9.83e-05	0.000559	CcSEcCtD
Norethindrone—Connective tissue disorder—Doxorubicin—kidney cancer	9.76e-05	0.000555	CcSEcCtD
Norethindrone—Dyspepsia—Capecitabine—kidney cancer	9.64e-05	0.000548	CcSEcCtD
Norethindrone—Asthenia—Paclitaxel—kidney cancer	9.57e-05	0.000545	CcSEcCtD
Norethindrone—Nausea—Gemcitabine—kidney cancer	9.46e-05	0.000539	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Capecitabine—kidney cancer	9.45e-05	0.000538	CcSEcCtD
Norethindrone—Fatigue—Capecitabine—kidney cancer	9.44e-05	0.000537	CcSEcCtD
Norethindrone—Pruritus—Paclitaxel—kidney cancer	9.44e-05	0.000537	CcSEcCtD
Norethindrone—Erythema multiforme—Doxorubicin—kidney cancer	9.39e-05	0.000534	CcSEcCtD
Norethindrone—Immune system disorder—Doxorubicin—kidney cancer	8.97e-05	0.000511	CcSEcCtD
Norethindrone—Gastrointestinal pain—Capecitabine—kidney cancer	8.95e-05	0.000509	CcSEcCtD
Norethindrone—Dizziness—Paclitaxel—kidney cancer	8.82e-05	0.000502	CcSEcCtD
Norethindrone—Alopecia—Doxorubicin—kidney cancer	8.78e-05	0.000499	CcSEcCtD
Norethindrone—Mental disorder—Doxorubicin—kidney cancer	8.7e-05	0.000495	CcSEcCtD
Norethindrone—Urticaria—Capecitabine—kidney cancer	8.7e-05	0.000495	CcSEcCtD
Norethindrone—Abdominal pain—Capecitabine—kidney cancer	8.65e-05	0.000492	CcSEcCtD
Norethindrone—Flatulence—Doxorubicin—kidney cancer	8.52e-05	0.000485	CcSEcCtD
Norethindrone—Tension—Doxorubicin—kidney cancer	8.49e-05	0.000483	CcSEcCtD
Norethindrone—Vomiting—Paclitaxel—kidney cancer	8.48e-05	0.000483	CcSEcCtD
Norethindrone—Rash—Paclitaxel—kidney cancer	8.41e-05	0.000479	CcSEcCtD
Norethindrone—Dermatitis—Paclitaxel—kidney cancer	8.4e-05	0.000478	CcSEcCtD
Norethindrone—Nervousness—Doxorubicin—kidney cancer	8.4e-05	0.000478	CcSEcCtD
Norethindrone—Headache—Paclitaxel—kidney cancer	8.36e-05	0.000476	CcSEcCtD
Norethindrone—Hypersensitivity—Capecitabine—kidney cancer	8.07e-05	0.000459	CcSEcCtD
Norethindrone—Nausea—Paclitaxel—kidney cancer	7.92e-05	0.000451	CcSEcCtD
Norethindrone—Asthenia—Capecitabine—kidney cancer	7.85e-05	0.000447	CcSEcCtD
Norethindrone—Pruritus—Capecitabine—kidney cancer	7.75e-05	0.000441	CcSEcCtD
Norethindrone—Convulsion—Doxorubicin—kidney cancer	7.49e-05	0.000426	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.31e-05	0.000416	CcSEcCtD
Norethindrone—Dizziness—Capecitabine—kidney cancer	7.24e-05	0.000412	CcSEcCtD
Norethindrone—Hydrocortisone—ABCB1—kidney cancer	7.23e-05	0.0423	CrCbGaD
Norethindrone—Anaphylactic shock—Doxorubicin—kidney cancer	7.06e-05	0.000402	CcSEcCtD
Norethindrone—Oedema—Doxorubicin—kidney cancer	7.06e-05	0.000402	CcSEcCtD
Norethindrone—Vomiting—Capecitabine—kidney cancer	6.96e-05	0.000396	CcSEcCtD
Norethindrone—Rash—Capecitabine—kidney cancer	6.9e-05	0.000393	CcSEcCtD
Norethindrone—Dermatitis—Capecitabine—kidney cancer	6.9e-05	0.000392	CcSEcCtD
Norethindrone—Headache—Capecitabine—kidney cancer	6.86e-05	0.00039	CcSEcCtD
Norethindrone—Skin disorder—Doxorubicin—kidney cancer	6.85e-05	0.00039	CcSEcCtD
Norethindrone—Nausea—Capecitabine—kidney cancer	6.5e-05	0.00037	CcSEcCtD
Norethindrone—Insomnia—Doxorubicin—kidney cancer	6.38e-05	0.000363	CcSEcCtD
Norethindrone—Somnolence—Doxorubicin—kidney cancer	6.27e-05	0.000357	CcSEcCtD
Norethindrone—Dyspepsia—Doxorubicin—kidney cancer	6.21e-05	0.000353	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.09e-05	0.000347	CcSEcCtD
Norethindrone—Fatigue—Doxorubicin—kidney cancer	6.08e-05	0.000346	CcSEcCtD
Norethindrone—Progesterone—ABCB1—kidney cancer	5.89e-05	0.0344	CrCbGaD
Norethindrone—Gastrointestinal pain—Doxorubicin—kidney cancer	5.77e-05	0.000328	CcSEcCtD
Norethindrone—Urticaria—Doxorubicin—kidney cancer	5.61e-05	0.000319	CcSEcCtD
Norethindrone—Abdominal pain—Doxorubicin—kidney cancer	5.58e-05	0.000317	CcSEcCtD
Norethindrone—Testosterone—ABCB1—kidney cancer	5.57e-05	0.0326	CrCbGaD
Norethindrone—Hypersensitivity—Doxorubicin—kidney cancer	5.2e-05	0.000296	CcSEcCtD
Norethindrone—Asthenia—Doxorubicin—kidney cancer	5.06e-05	0.000288	CcSEcCtD
Norethindrone—Pruritus—Doxorubicin—kidney cancer	4.99e-05	0.000284	CcSEcCtD
Norethindrone—Dizziness—Doxorubicin—kidney cancer	4.67e-05	0.000266	CcSEcCtD
Norethindrone—Vomiting—Doxorubicin—kidney cancer	4.49e-05	0.000255	CcSEcCtD
Norethindrone—Rash—Doxorubicin—kidney cancer	4.45e-05	0.000253	CcSEcCtD
Norethindrone—Dermatitis—Doxorubicin—kidney cancer	4.45e-05	0.000253	CcSEcCtD
Norethindrone—Headache—Doxorubicin—kidney cancer	4.42e-05	0.000252	CcSEcCtD
Norethindrone—Nausea—Doxorubicin—kidney cancer	4.19e-05	0.000239	CcSEcCtD
Norethindrone—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.18e-05	0.000664	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—MYC—kidney cancer	1.18e-05	0.000659	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.17e-05	0.000657	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PAK1—kidney cancer	1.17e-05	0.000654	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUNB—kidney cancer	1.17e-05	0.000654	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPAT—kidney cancer	1.16e-05	0.000649	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.16e-05	0.000649	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.14e-05	0.000641	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.14e-05	0.000641	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000637	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.14e-05	0.000637	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PGK1—kidney cancer	1.14e-05	0.000637	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.13e-05	0.000635	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GLIPR1—kidney cancer	1.13e-05	0.000634	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPAT—kidney cancer	1.13e-05	0.000634	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPC3—kidney cancer	1.13e-05	0.000632	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.13e-05	0.000632	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LDHB—kidney cancer	1.11e-05	0.000624	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IFNA2—kidney cancer	1.11e-05	0.000621	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.1e-05	0.000617	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA2—kidney cancer	1.1e-05	0.000615	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APRT—kidney cancer	1.08e-05	0.000604	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FH—kidney cancer	1.08e-05	0.000604	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ALAD—kidney cancer	1.07e-05	0.000599	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.06e-05	0.000597	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.06e-05	0.000596	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000592	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.05e-05	0.00059	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FH—kidney cancer	1.05e-05	0.000589	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APRT—kidney cancer	1.05e-05	0.000589	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.05e-05	0.000588	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ST3GAL2—kidney cancer	1.04e-05	0.000585	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.04e-05	0.000581	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ALDH1A1—kidney cancer	1.02e-05	0.000572	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.01e-05	0.000569	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPC3—kidney cancer	1.01e-05	0.000568	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACY1—kidney cancer	1e-05	0.000563	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF2—kidney cancer	9.97e-06	0.000559	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPC3—kidney cancer	9.88e-06	0.000554	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA2—kidney cancer	9.85e-06	0.000552	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PGK1—kidney cancer	9.78e-06	0.000548	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC5A3—kidney cancer	9.78e-06	0.000548	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CA9—kidney cancer	9.65e-06	0.000541	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.65e-06	0.000541	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ACHE—kidney cancer	9.63e-06	0.00054	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTT1—kidney cancer	9.63e-06	0.00054	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA2—kidney cancer	9.61e-06	0.000539	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	9.6e-06	0.000539	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALAD—kidney cancer	9.6e-06	0.000538	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LDHB—kidney cancer	9.59e-06	0.000538	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	9.55e-06	0.000535	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF2—kidney cancer	9.54e-06	0.000535	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN2B—kidney cancer	9.5e-06	0.000532	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALAD—kidney cancer	9.37e-06	0.000525	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ST3GAL2—kidney cancer	9.37e-06	0.000525	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.32e-06	0.000522	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1R—kidney cancer	9.22e-06	0.000517	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.16e-06	0.000514	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALDH1A1—kidney cancer	9.16e-06	0.000513	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ST3GAL2—kidney cancer	9.14e-06	0.000513	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.14e-06	0.000513	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SCARB1—kidney cancer	9.11e-06	0.000511	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.07e-06	0.000509	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS1—kidney cancer	9.02e-06	0.000506	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDH1A1—kidney cancer	8.94e-06	0.000501	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PSMD7—kidney cancer	8.85e-06	0.000496	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.84e-06	0.000496	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PGK1—kidney cancer	8.78e-06	0.000492	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC5A3—kidney cancer	8.78e-06	0.000492	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LDHB—kidney cancer	8.61e-06	0.000483	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PGK1—kidney cancer	8.57e-06	0.00048	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC5A3—kidney cancer	8.57e-06	0.00048	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PDHB—kidney cancer	8.54e-06	0.000479	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—POMC—kidney cancer	8.52e-06	0.000478	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LDHB—kidney cancer	8.4e-06	0.000471	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.4e-06	0.000471	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—BCHE—kidney cancer	8.39e-06	0.00047	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA9—kidney cancer	8.31e-06	0.000466	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC5A5—kidney cancer	8.28e-06	0.000465	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CRABP1—kidney cancer	8.21e-06	0.00046	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.13e-06	0.000456	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	8.11e-06	0.000455	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CCBL1—kidney cancer	8.03e-06	0.00045	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC2A1—kidney cancer	8e-06	0.000449	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.99e-06	0.000448	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.67e-06	0.00043	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ITPR2—kidney cancer	7.63e-06	0.000428	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HIF1A—kidney cancer	7.59e-06	0.000426	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TSC2—kidney cancer	7.57e-06	0.000425	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.56e-06	0.000424	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA9—kidney cancer	7.46e-06	0.000419	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.35e-06	0.000412	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	7.3e-06	0.000409	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.3e-06	0.000409	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA9—kidney cancer	7.29e-06	0.000408	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KDR—kidney cancer	7.26e-06	0.000407	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.19e-06	0.000403	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CRABP1—kidney cancer	7.07e-06	0.000396	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPAT—kidney cancer	6.97e-06	0.000391	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.97e-06	0.000391	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTT1—kidney cancer	6.96e-06	0.00039	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ACHE—kidney cancer	6.96e-06	0.00039	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.79e-06	0.000381	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APC—kidney cancer	6.69e-06	0.000375	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KIT—kidney cancer	6.69e-06	0.000375	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTP1—kidney cancer	6.67e-06	0.000374	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SCARB1—kidney cancer	6.59e-06	0.000369	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ITPR2—kidney cancer	6.57e-06	0.000369	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS1—kidney cancer	6.52e-06	0.000366	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APRT—kidney cancer	6.48e-06	0.000363	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FH—kidney cancer	6.48e-06	0.000363	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PSMD7—kidney cancer	6.4e-06	0.000359	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—POMC—kidney cancer	6.37e-06	0.000357	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CRABP1—kidney cancer	6.35e-06	0.000356	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.34e-06	0.000355	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—kidney cancer	6.32e-06	0.000354	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BRAF—kidney cancer	6.29e-06	0.000352	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.24e-06	0.00035	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CRABP1—kidney cancer	6.19e-06	0.000347	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—kidney cancer	6.13e-06	0.000344	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPC3—kidney cancer	6.09e-06	0.000341	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—BCHE—kidney cancer	6.06e-06	0.00034	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.06e-06	0.00034	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.04e-06	0.000338	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ACHE—kidney cancer	5.99e-06	0.000336	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTT1—kidney cancer	5.99e-06	0.000336	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC5A5—kidney cancer	5.99e-06	0.000336	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA2—kidney cancer	5.92e-06	0.000332	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ITPR2—kidney cancer	5.9e-06	0.000331	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MAPK3—kidney cancer	5.82e-06	0.000326	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP1A1—kidney cancer	5.81e-06	0.000326	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC2A1—kidney cancer	5.78e-06	0.000324	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALAD—kidney cancer	5.77e-06	0.000324	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ITPR2—kidney cancer	5.76e-06	0.000323	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SCARB1—kidney cancer	5.67e-06	0.000318	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—kidney cancer	5.66e-06	0.000317	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.63e-06	0.000316	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS1—kidney cancer	5.62e-06	0.000315	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMD7—kidney cancer	5.51e-06	0.000309	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.51e-06	0.000309	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—RAF1—kidney cancer	5.49e-06	0.000308	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.44e-06	0.000305	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTT1—kidney cancer	5.38e-06	0.000302	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ACHE—kidney cancer	5.38e-06	0.000302	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PGK1—kidney cancer	5.28e-06	0.000296	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.28e-06	0.000296	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ACHE—kidney cancer	5.25e-06	0.000294	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTT1—kidney cancer	5.25e-06	0.000294	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RAF1—kidney cancer	5.25e-06	0.000294	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RELA—kidney cancer	5.23e-06	0.000293	CbGpPWpGaD
Norethindrone—ALB—Metabolism—BCHE—kidney cancer	5.22e-06	0.000293	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ERBB2—kidney cancer	5.19e-06	0.000291	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LDHB—kidney cancer	5.18e-06	0.00029	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC5A5—kidney cancer	5.16e-06	0.000289	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MTOR—kidney cancer	5.13e-06	0.000287	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SCARB1—kidney cancer	5.09e-06	0.000286	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS1—kidney cancer	5.04e-06	0.000283	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A1—kidney cancer	4.98e-06	0.000279	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SCARB1—kidney cancer	4.97e-06	0.000279	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMD7—kidney cancer	4.94e-06	0.000277	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS1—kidney cancer	4.92e-06	0.000276	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—kidney cancer	4.92e-06	0.000276	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.83e-06	0.000271	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMD7—kidney cancer	4.83e-06	0.000271	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—kidney cancer	4.82e-06	0.00027	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—kidney cancer	4.81e-06	0.00027	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.75e-06	0.000266	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—kidney cancer	4.71e-06	0.000264	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BCHE—kidney cancer	4.69e-06	0.000263	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.63e-06	0.00026	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—kidney cancer	4.59e-06	0.000257	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—kidney cancer	4.58e-06	0.000257	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BCHE—kidney cancer	4.58e-06	0.000257	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—kidney cancer	4.57e-06	0.000256	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—kidney cancer	4.54e-06	0.000255	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC5A5—kidney cancer	4.52e-06	0.000253	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA9—kidney cancer	4.49e-06	0.000252	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.47e-06	0.000251	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—kidney cancer	4.43e-06	0.000249	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTEN—kidney cancer	4.43e-06	0.000248	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A1—kidney cancer	4.36e-06	0.000245	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.34e-06	0.000243	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—kidney cancer	4.33e-06	0.000243	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.21e-06	0.000236	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.2e-06	0.000236	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—kidney cancer	4.18e-06	0.000234	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.16e-06	0.000233	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—kidney cancer	4.15e-06	0.000233	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—kidney cancer	4e-06	0.000224	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK3—kidney cancer	3.96e-06	0.000222	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—kidney cancer	3.93e-06	0.00022	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—kidney cancer	3.82e-06	0.000214	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CRABP1—kidney cancer	3.82e-06	0.000214	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK3—kidney cancer	3.78e-06	0.000212	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.78e-06	0.000212	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK1—kidney cancer	3.76e-06	0.000211	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—kidney cancer	3.73e-06	0.000209	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—kidney cancer	3.68e-06	0.000206	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—kidney cancer	3.64e-06	0.000204	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1A1—kidney cancer	3.62e-06	0.000203	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK1—kidney cancer	3.6e-06	0.000202	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—kidney cancer	3.55e-06	0.000199	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ITPR2—kidney cancer	3.55e-06	0.000199	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—kidney cancer	3.53e-06	0.000198	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—kidney cancer	3.46e-06	0.000194	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—kidney cancer	3.43e-06	0.000192	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—kidney cancer	3.4e-06	0.000191	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—kidney cancer	3.35e-06	0.000188	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—kidney cancer	3.27e-06	0.000183	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.25e-06	0.000182	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—kidney cancer	3.24e-06	0.000181	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACHE—kidney cancer	3.24e-06	0.000181	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1A1—kidney cancer	3.17e-06	0.000178	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—kidney cancer	3.16e-06	0.000177	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—kidney cancer	3.13e-06	0.000176	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—kidney cancer	3.12e-06	0.000175	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SCARB1—kidney cancer	3.06e-06	0.000172	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS1—kidney cancer	3.03e-06	0.00017	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—kidney cancer	3.02e-06	0.000169	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTEN—kidney cancer	3.02e-06	0.000169	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.97e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMD7—kidney cancer	2.97e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BCHE—kidney cancer	2.82e-06	0.000158	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.78e-06	0.000156	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—kidney cancer	2.7e-06	0.000151	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.69e-06	0.000151	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.67e-06	0.00015	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—kidney cancer	2.5e-06	0.00014	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—kidney cancer	2.42e-06	0.000136	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—kidney cancer	2.36e-06	0.000133	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.24e-06	0.000126	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTEN—kidney cancer	2.18e-06	0.000122	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—kidney cancer	2.15e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.13e-06	0.000119	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.12e-06	0.000119	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.06e-06	0.000116	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.95e-06	0.00011	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—kidney cancer	1.93e-06	0.000108	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—kidney cancer	1.89e-06	0.000106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTEN—kidney cancer	1.88e-06	0.000105	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTEN—kidney cancer	1.69e-06	9.45e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTEN—kidney cancer	1.64e-06	9.22e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.54e-06	8.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—kidney cancer	1.46e-06	8.17e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—kidney cancer	1.32e-06	7.42e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.19e-06	6.66e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.16e-06	6.51e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.16e-06	6.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTEN—kidney cancer	1.01e-06	5.68e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.15e-07	4.01e-05	CbGpPWpGaD
